ArticleBMC cancer2016

(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges.

Tatiana C Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.